Retraction Note: Journal of Hematology & Oncology (2020) 13:24 https://doi.org/10.1186/s13045-020-00857-7
The Editor-in-Chief has retracted this article. After publication, concerns were raised about image reuse in the article. Specifically:
The top-left panel of Fig. 2F was reproduced in two panels of Fig. 4H, and in Fig. S11E of the supplementary materials.
There is overlap between the top-left panel of Fig. 2G and the second-from-top-right panel of Fig. 4I.
There is overlap between the top-left panel of Fig. 4I and the bottom-left panel of Fig. 5G.
There is overlap between the second-from-bottom-left panel of Fig. 4I and the top-right panel of Fig. 5G.
There is overlap between the bottom middle panel of Fig. 5G and the bottom-right panel of Fig. S7B of the supplementary materials.
Additionally, the top-left panel of Fig. 2F was found to have previously been published in [1] by some of the same authors. The Editor-in-Chief no longer has confidence in the data reported in the article.
Qiangsong Tong has stated on behalf of all authors that they do not agree to this retraction.
Reference
Zheng L, Jiao W, Mei H, Song H, Li D, Xiang X, Chen Y, Yang F, Li H, Huang K, Tong Q. miRNA-337-3p inhibits gastric cancer progression through repressing myeloid zinc finger 1-facilitated expression of matrix metalloproteinase 14. Oncotarget. 2016;7:40314–28.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Song, H., Li, D., Wang, X. et al. Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression. J Hematol Oncol 16, 95 (2023). https://doi.org/10.1186/s13045-023-01493-7
Published:
DOI: https://doi.org/10.1186/s13045-023-01493-7